Display options
Share it on

J Am Acad Dermatol. 2009 Oct;61(4):677.e1-14. doi: 10.1016/j.jaad.2009.03.016.

Selection criteria for genetic assessment of patients with familial melanoma.

Journal of the American Academy of Dermatology

Sancy A Leachman, John Carucci, Wendy Kohlmann, Kimberly C Banks, Maryam M Asgari, Wilma Bergman, Giovanna Bianchi-Scarrà, Teresa Brentnall, Brigitte Bressac-de Paillerets, William Bruno, Clara Curiel-Lewandrowski, Femke A de Snoo, Tadeusz Debniak, Marie-France Demierre, David Elder, Alisa M Goldstein, Jane Grant-Kels, Allan C Halpern, Christian Ingvar, Richard F Kefford, Julie Lang, Rona M MacKie, Graham J Mann, Kurt Mueller, Julia Newton-Bishop, Håkan Olsson, Gloria M Petersen, Susana Puig, Darrell Rigel, Susan M Swetter, Margaret A Tucker, Emanuel Yakobson, John A Zitelli, Hensin Tsao

Affiliations

  1. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112-5550, USA. [email protected]

PMID: 19751883 PMCID: PMC3307795 DOI: 10.1016/j.jaad.2009.03.016

Abstract

Approximately 5% to 10% of melanoma may be hereditary in nature, and about 2% of melanoma can be specifically attributed to pathogenic germline mutations in cyclin-dependent kinase inhibitor 2A (CDKN2A). To appropriately identify the small proportion of patients who benefit most from referral to a genetics specialist for consideration of genetic testing for CDKN2A, we have reviewed available published studies of CDKN2A mutation analysis in cohorts with invasive, cutaneous melanoma and found variability in the rate of CDKN2A mutations based on geography, ethnicity, and the type of study and eligibility criteria used. Except in regions of high melanoma incidence, such as Australia, we found higher rates of CDKN2A positivity in individuals with 3 or more primary invasive melanomas and/or families with at least one invasive melanoma and two or more other diagnoses of invasive melanoma and/or pancreatic cancer among first- or second-degree relatives on the same side of the family. The work summarized in this review should help identify individuals who are appropriate candidates for referral for genetic consultation and possible testing.

References

  1. Arch Dermatol. 2003 Aug;139(8):1019-25 - PubMed
  2. Br J Dermatol. 2004 Mar;150(3):531-6 - PubMed
  3. Am J Med Genet. 2002 Jan 22;107(3):214-21 - PubMed
  4. J Invest Dermatol. 2004 May;122(5):1327-30 - PubMed
  5. Genes Chromosomes Cancer. 2000 Apr;27(4):358-61 - PubMed
  6. J Natl Cancer Inst. 2002 Jun 19;94(12):894-903 - PubMed
  7. J Invest Dermatol. 1998 Aug;111(2):269-72 - PubMed
  8. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8541-5 - PubMed
  9. Br J Cancer. 2004 Jan 26;90(2):503-9 - PubMed
  10. N Engl J Med. 1998 Mar 26;338(13):879-87 - PubMed
  11. N Engl J Med. 1998 Jul 30;339(5):348-9 - PubMed
  12. Cancer Res. 2000 Dec 15;60(24):6864-7 - PubMed
  13. Am J Hum Genet. 2001 Oct;69(4):765-73 - PubMed
  14. Arch Dermatol Res. 2001 Nov;293(10):540-2 - PubMed
  15. Br J Cancer. 2005 Jun 20;92(12):2278-85 - PubMed
  16. Br J Cancer. 2001 Sep 14;85(6):836-44 - PubMed
  17. Cancer. 1994 Dec 15;74(12):3118-25 - PubMed
  18. J Natl Cancer Inst. 2000 Jun 21;92(12):1006-10 - PubMed
  19. J Natl Cancer Inst. 2005 Oct 19;97(20):1507-15 - PubMed
  20. Melanoma Res. 2004 Dec;14(6):443-8 - PubMed
  21. J Am Acad Dermatol. 2007 May;56(5):748-52 - PubMed
  22. Int J Cancer. 1999 Nov 12;83(4):441-8 - PubMed
  23. Lancet Oncol. 2002 Nov;3(11):653-4 - PubMed
  24. Gastroenterology. 2000 Dec;119(6):1756-60 - PubMed
  25. J Med Genet. 1999 Jun;36(6):490-3 - PubMed
  26. Clin Exp Dermatol. 2005 Jan;30(1):68-70 - PubMed
  27. J Clin Oncol. 2004 Jan 1;22(1):39-44 - PubMed
  28. J Natl Cancer Inst. 2000 Aug 2;92(15):1260-6 - PubMed
  29. Br J Cancer. 1999 Apr;80(1-2):295-300 - PubMed
  30. Hum Mol Genet. 1998 Feb;7(2):209-16 - PubMed
  31. Int J Cancer. 2004 Jul 1;110(4):558-62 - PubMed
  32. Arch Dermatol. 2000 Sep;136(9):1118-22 - PubMed
  33. Cancer Res. 2000 Jan 15;60(2):409-16 - PubMed
  34. Cancer. 2002 Jan 1;94(1):84-96 - PubMed
  35. Int J Cancer. 2002 Mar 1;98(1):92-8 - PubMed
  36. J Med Genet. 2007 Feb;44(2):99-106 - PubMed
  37. Cancer. 2003 Aug 15;98(4):798-804 - PubMed
  38. J Invest Dermatol. 1998 Dec;111(6):1202-6 - PubMed
  39. Recent Results Cancer Res. 1995;139:87-104 - PubMed
  40. Oncogene. 1997 Dec 11;15(24):2999-3005 - PubMed
  41. Pancreas. 2000 Nov;21(4):369-75 - PubMed
  42. Acta Biochim Pol. 2002;49(2):369-76 - PubMed
  43. Melanoma Res. 2004 Aug;14(4):251-5 - PubMed
  44. Braz J Med Biol Res. 2006 Feb;39(2):237-41 - PubMed
  45. J Clin Oncol. 2007 Nov 20;25(33):5336-7; author reply 5337-8 - PubMed
  46. Genes Chromosomes Cancer. 1999 Aug;25(4):339-48 - PubMed
  47. Int J Cancer. 2000 Sep 15;87(6):809-11 - PubMed
  48. Cancer. 2004 Dec 15;101(12):2809-16 - PubMed
  49. J Med Genet. 2003 Aug;40(8):e102 - PubMed
  50. Genes Chromosomes Cancer. 2001 Nov;32(3):195-202 - PubMed
  51. J Clin Oncol. 2005 May 1;23(13):3043-51 - PubMed
  52. Diagn Mol Pathol. 1997 Apr;6(2):85-90 - PubMed
  53. Cancer Res. 2006 Oct 15;66(20):9818-28 - PubMed
  54. Clin Cancer Res. 2008 Nov 1;14(21):7151-7 - PubMed
  55. J Invest Dermatol. 2000 Jan;114(1):28-33 - PubMed
  56. J Natl Cancer Inst. 1997 Oct 1;89(19):1460 - PubMed
  57. J Invest Dermatol. 2006 Feb;126(2):399-401 - PubMed
  58. Arch Dermatol. 1999 Mar;135(3):261-5 - PubMed
  59. J Med Genet. 2004 Jul;41(7):557-66 - PubMed
  60. N Engl J Med. 1995 Oct 12;333(15):970-4 - PubMed
  61. J Natl Cancer Inst. 1997 May 21;89(10):697-702 - PubMed
  62. JAMA. 2005 Oct 5;294(13):1647-54 - PubMed
  63. J Natl Cancer Inst. 1999 Mar 3;91(5):446-52 - PubMed
  64. Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):889-94 - PubMed
  65. Melanoma Res. 1995 Jun;5(3):169-77 - PubMed
  66. J Med Genet. 1978 Oct;15(5):352-6 - PubMed
  67. Nat Genet. 1994 Sep;8(1):23-6 - PubMed
  68. Eur J Cancer Prev. 2008 Oct;17(5):389-91 - PubMed
  69. Hum Mutat. 1998;12(1):70 - PubMed
  70. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1510-9 - PubMed
  71. Hum Mutat. 2004 Jun;23(6):630 - PubMed
  72. Int J Cancer. 2007 Aug 15;121(4):825-31 - PubMed
  73. Am J Med Genet A. 2003 Apr 30;118A(3):201-9 - PubMed
  74. Eur J Cancer. 2007 Jan;43(1):137-43 - PubMed
  75. J Clin Oncol. 2005 Oct 1;23(28):7168-77 - PubMed
  76. J Invest Dermatol. 2005 Dec;125(6):1310-2 - PubMed
  77. Eur J Hum Genet. 2000 Aug;8(8):590-6 - PubMed
  78. Melanoma Res. 2002 Dec;12(6):559-63 - PubMed
  79. Cancer. 2002 Apr 15;94(8):2248-55 - PubMed
  80. J Invest Dermatol. 2006 Mar;126(3):660-6 - PubMed
  81. J Natl Cancer Inst. 2004 May 19;96(10):785-95 - PubMed
  82. Ann Surg. 2002 Dec;236(6):730-7 - PubMed
  83. Melanoma Res. 2005 Dec;15(6):555-8 - PubMed
  84. Br J Dermatol. 2005 Dec;153(6):1121-5 - PubMed
  85. Hum Mol Genet. 1997 Nov;6(12):2061-7 - PubMed
  86. Croat Med J. 2006 Dec;47(6):851-4 - PubMed
  87. J Clin Oncol. 2003 Jun 15;21(12):2397-406 - PubMed
  88. J Med Genet. 2006 Jun;43(6):501-6 - PubMed
  89. J Am Acad Dermatol. 1990 Jan;22(1):117-8 - PubMed
  90. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3598-605 - PubMed
  91. Nat Genet. 1999 Jan;21(1):128-32 - PubMed
  92. Ann Oncol. 2004 Jan;15(1):70-8 - PubMed
  93. J Am Acad Dermatol. 1999 Sep;41(3 Pt 1):461-2 - PubMed

MeSH terms

Publication Types

Grant support